[Biosimilars in Inflammatory Bowel Disease (IBD): Experiences and perceptions of german gastroenterologists]. [electronic resource]
- Zeitschrift fur Gastroenterologie Apr 2017
- 369-374 p. digital
Publication Type: Journal Article
1439-7803
10.1055/s-0042-121520 doi
Biosimilar Pharmaceuticals--therapeutic use Gastroenterologists Gastrointestinal Agents--therapeutic use Germany Humans Inflammatory Bowel Diseases--drug therapy Infliximab--therapeutic use Practice Patterns, Physicians' Prescriptions Surveys and Questionnaires Tumor Necrosis Factor-alpha